Sanofi (SNY) Acquisitions (2023 - 2026)

Sanofi has disclosed Acquisitions across 4 years of filings, most recently posting -$2.0 billion for Q1 2026.

• Acquisitions for Q1 2026 came in at -$2.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.6 billion (changed N/A YoY), and the FY2025 annual result was -$12.8 billion, down 377.35% from the prior year.
• Acquisitions came in at -$2.0 billion for Q1 2026 at Sanofi, up from -$12.8 billion in the prior quarter.
• In the past five years, Acquisitions ranged from a high of -$90.2 million in Q1 2024 to a low of -$12.8 billion in Q4 2025.
• The 4-year median for Acquisitions is -$2.7 billion (2024), against an average of -$4.2 billion.
• Across the five-year window, Acquisitions gained 20.87% in 2024 and tumbled 376.97% in 2025, its largest moves.
• Sanofi's Acquisitions stood at -$3.4 billion in 2023, then increased by 20.87% to -$2.7 billion in 2024, then sank by 376.97% to -$12.8 billion in 2025, then surged by 84.41% to -$2.0 billion in 2026.
• The last three Acquisitions figures came in at -$2.0 billion (Q1 2026), -$12.8 billion (Q4 2025), and -$2.7 billion (Q4 2024), per Business Quant data.